<DOC>
	<DOC>NCT01817803</DOC>
	<brief_summary>To compare the effectiveness and safety of diuretics add-on strategy in chronic heart failure patients</brief_summary>
	<brief_title>A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>1. dyspnea at rest or minimal activity 2. tachypnea (respiratory rate &gt; 20/min) or rales or pulmonary edema on chest Xray 3. who need diuretics add over 40mg of daily furosemide dose 1. Hospitalization for acute heart failure decompensation 2. cardiogenic shock (Systolic Blood Pressure &lt; 80mmHg) 3. Need or plan for renal replacement therapy (dialysis, kidney transplant) 4. serum creatine level &gt; 2.5mg/dl 5. serum potassium (K+) &gt; 5.5mg/dl 6. daily spironolactone dose &gt; 50mg 7. previous thiazide or metolazone user 8. Age &gt; 75 years old or poor compliance patients 9. allergy, adverse drug reaction, hypersensitivity to any kinds of diuretics 10. life expectancy &lt; 6 months (e.g. metastatic malignancy, liver cirrhosis) 11. pregnancy or women at age of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>diuretics</keyword>
	<keyword>kidney</keyword>
	<keyword>glomerular filtration rate</keyword>
</DOC>